SCHEMBL18232172

SCHEMBL18232172

CC(C)(C)c1nc(-c2ccccc2-c2ccccc2)c2ccccc2n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
MAPT P10636 4/20 0.44
LMNA P02545 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
PLA2G1B P04054 1/20 0.44
ATG4B Q9Y4P1 1/20 0.44
ADORA2A P29274 6/20 0.43
NUDT1 P36639 3/20 0.41
PRNP P04156 2/20 0.41
HTT P42858 1/20 0.39
GAA P10253 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CCNE2 O96020 2/20 0.38
CDK4 P11802 2/20 0.38
CCND1 P24385 2/20 0.38
CCNE1 P24864 2/20 0.38
CDK2 P24941 2/20 0.38
CCNB2 O95067 1/20 0.38
CDK1 P06493 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16520903 0.86 ADORA2A (0.55) ALDH1A1MAPTLMNAL3MBTL1PLA2G1B
SCHEMBL25817444 0.86 SCD (0.38) ALDH1A1MAPTLMNAL3MBTL1PLA2G1B
SCHEMBL19161955 0.84 ALDH1A1 (0.44) ALDH1A1MAPTLMNAL3MBTL1PLA2G1B
SCHEMBL25877827 0.84 ADORA2A (0.43) ALDH1A1MAPTLMNAL3MBTL1PLA2G1B
SCHEMBL18232171 0.83 ADORA2A (0.51) ALDH1A1MAPTLMNAL3MBTL1PLA2G1B
SCHEMBL25833574 0.82 ALDH1A1 (0.37) ALDH1A1MAPTLMNAL3MBTL1PLA2G1B
SCHEMBL25878131 0.81 ALDH1A1 (0.37) ALDH1A1MAPTLMNAL3MBTL1PLA2G1B
SCHEMBL20052625 0.80 MEN1 (0.40) ALDH1A1MAPTLMNAMEN1KMT2A
SCHEMBL19161957 0.79 ALDH1A1 (0.40) ALDH1A1MAPTLMNAL3MBTL1PLA2G1B
SCHEMBL18232159 0.79 ADORA2A (0.46) ALDH1A1MAPTLMNAL3MBTL1PLA2G1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192669-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 US disclosed
US-20230192669-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 US disclosed
US-9947878-B2 Organic light-emitting device LG CHEM, LTD. (KR) 2018-04-17 US disclosed
US-20170012217-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2017-01-12 US disclosed
US-20160336518-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2016-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192669-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS ACHE, OR51E2, L1CAM ALDH1A1 213/4885MAPT 1215/4885LMNA 2446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.